DR. YASUHIRO YAMAMURA

NAME

Yasuhiro Yamamura, PhD

TITLE

Professor, Department of Microbiology

EDUCATION AND TRAINING
INSTITUTION AND LOCATION DEGREE YEAR(s) FIELD OF STUDY

Tokyo Univ. Agr. Technol.,Tokyo, JPN
Univ. Guelph, Guelph, Ontario, CND
Univ. Michigan, Ann Arbor, MI.

BSc
MS
PhD

1963
1968
1973

Appid Microbiology
Microbiology
Epid. Sci (Virology)

POSITIONS AND HONORS


1963-1967

1973-1974

1974-1976

1977-1979

1979-1981

1981-1985

1985—

1990—

 


Research Associate, Research Division of Microbiology, Taisho Pharm. Co., Ltd., Tokyo, Japan

Post-Doctoral Research Fellow (NCI of Canada), McGill Univ. Cancer Research Unit, McGill
Univ. Sch. Medicine, Montreal, PQ, CND.

Research Associate/Instructor, Dept. Basic & Clinical Immunol. Microbiol., Medical Univ. South
Carolina, Charleston, SC.

Associate Scientist, Clinical Radiation Research Center, Cancer Research Unit, Allegheny General
Hospital/Singer Research Corp., Pittsburgh, PA.

Assistant Professor, Dept. Basic & Clinical Immunol. Microbiol., Medical Univ. South Carolina,
Charleston , SC.

Associate Professor, Department of Pathology, Loyola Univ. Chicago, School of Medicine,
Maywood, IL.

Professor, Department of Microbiology, Ponce School of Medicine, Ponce, PR.

Director, AIDS Research Program, Ponce School of Medicine, Ponce, PR.

 
Publications (2000-present)

M. P. Carlos, D. E. Anderson, Q. K. Vu, K. Conzen, A. Yim, F. Diaz-Mitoma, Y, Yamamura and Torres, JV. A vaccine to circumvent the genetic variation and immune selection pressure of hepatitis C virus.
Clinical Immunology. 103 (3):S101. 2002.

M. P. Carlos, Y. Yamamura. Q. Vu, D. E. Anderson, F. Diaz-Mitoma, and J. V. Torres. Immune evasion strategy of HIV-1 directed against the hypervariable regions VI through V3 of the envelope glycoprotein. Proc. XIV Intern AIDS Conf.; 241-246 (2002)

J. C. Anderson, J. Simonetti, D. G. Fisher, J. Williams, Y. Yamamura, N. Rodriguez, D. G. Sullivan, D. R. Gritch, B. McMahon, K. J. Williams. Comparison of different HCV viral load and genotyping assays. J. Clin. Virol. (accepted) (2002)

Abstracts

W. Rivera, S. Otero, N. Rodriguez, & Y. Yamamura. Distinct patterns of T lymphocyte responses to HCV antigens: acute and chronic HCV cases vs "immune" HCV. SILCIBIO/Nocardiae-2000, Sept. 2000, Davis, CA

G. Tirado, A. Valdivieso, G. Sepulveda, A. Soto, & Y. Yamamura. HP/ evolution & drug resistance patterns:plasma vs vaginal compartments. SILCIBIO/Nocardiae-2000, Sept. 2000, Davis, CA

S. Otero, M-C. Colon, M. Sepulveda, & Y. Yamamura. Increased risk of AIDS dementia complex (ADC): a mechanism involving cocaine usage and CCR5 expression. SILCIBIO/Nocardiae-2000, Sept. 2000, Davis, CA

Y. Yamamura. HP/-1/HCV Dual Infection: An Emerging Issue. SILCIBIO/Nocardiae-2000, Sept. 2000, Davis, CA

S. Otero, W. Rivera, M-C-. Colon, M. Sepulveda, & Y. Yamamura. Cicaine uses and CCR5 expression: a mechanism of increased AIDS dementia complex (ADC) in injecting drug users (IDUs). 7th RCMI International symposium on Health Disparity. Nov. 2000, San Juan, PR

W. Rivera, S. Otero, N. Rodriguez, & Y. Yamamura. Patterns ofTcell responses to HCV epitopes differentiate "active" HCV cases from "immune" HCV. 7th RCMI Intern. Symp. Health Disparity. Nov. 2000, San Juan, PR.

N. Rodriguez, G. Tirado, A. Valdivieso, & Y. Yamamura. Patterns & incidences of primary drug resistance mutations among HIV-1 positive Puerto Ricans under treatment. 7th RCMI Intern. Symp. Health Disparity. Nov. 2000. San Juan, PR.

G. Tirado, A. Vaildivieso, G. Sepulveda, A. Soto & Y. Yamamura. Evolution and drug resistance patterns are distinct between vaginal and plasma HP/ compartments of female. 7th RCMI Intern. Symp. Health Disparity. Nov. 2000, San Juan, PR.

M. F. Cobo, D. V. Jobes, R. Yanagihara, V. R. Nerurkar, C. F. Ryschkewitsch, Y. Yamamura, W. Silva, & G. L.Stoner. Reconstructing population history with JC virus: Amerinds, Spanish and Africans in the ancestry ofmodem-day Puerto Ricans. 7th RCMI Intern. Symp. Health Disparity. Nov. 2000, San Juan, PR.

C. F. Rios-Bedoya, S. Abreu, & Y. Yamamura. HIUV genotyping as an indicator of treatment efficacy in PuertoRico. 7th RCMI Intern. Symp. Health Disparity. Nov. 2000, San Juan, PR.

Y. Yamamura, C. Rivera, S. Otero & M. Sepulveda. CCR5 upregulation in injecting cocaine users as a risk factor of HIV-associated dementia (HAD). 8th Conference on Retroviruses and Opportunistic Infections. February, 2001. Chicago, n

Y, Yamamura, G. Tirado, A. Soto, G. Sepulveda, & C. Zorrilla. Resident HP/ of vaginal compartment are distinct from plasma HP/ in both drug resistance mutation patterns and viral evolution. 8th Conference on Retroviruses and Opportunistic Infections. February, 2001, Chicago, H

M. P. Carlos, Y. Yamamura. Q. Vu, D. E. Anderson, F. Diaz-Mitoma, and J. V. Torres. Immune evasion strategy of HIV-1 directed against the hypervariable regions VI through V3 of the envelope glycoprotein. XIV Intern AIDS Conf.; July 1-12, 2002, Barcelona, Sapain

Active & Future Projects:

Genital HP/-1 compartment in heterosexual transmission (Y. Yamamura, PhD, 20), S06 GM08239 (MBRS, J. Torres-Ruiz, PhD, PI) (06/01/01 -05/30/05)

Immunogenicity of inactivated polio vaccine in Puerto Rico, a comparative cohort study of two vaccination
schedules (2002-N-00418). (Y. Yamamura, PhD PI) (10/01/02-03/31/03)

Chronic drug abuses increase HP/-1 susceptibility in vivo (PAS-23-001) (Y. Yamamura, PhD)
(NIDA: submitted)

The development of a Center of Excellence for the purpose of studying the "Puerto Rican Culture and Its Influence on the Biomedical, Socio-Behavioral, and Mental Health Aspects of Health Disparities Associated with the AIDS/HIV-1 Infection". (Y. Yamamura, PhD)(2005)

The exploration of childhood sexual abuse as a possible predictive factor of adherence to antiretroviral treatment in HIV positive patients (Y. Yamamura, PhD)(2005)

Cocaine abuse as a major cofactor of HIV-1 infection in Puerto Rico (Y. Yamamura, PhD)(2005)


Lab. Personnel:

For current lab members go to:

http://www.psm.edu/aids_research/staff/index.html

 

Back to Top